|
|
Volumn 25, Issue 4, 2007, Pages 145-149
|
|
Nitric oxide and vascular disease
|
|
Author keywords
atherosclerosis; cholesterol; endothelium; nitric oxide
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIOXIDANT;
ASCORBIC ACID;
C REACTIVE PROTEIN;
ENDOTHELIAL NITRIC OXIDE SYNTHASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MESSENGER RNA;
NITRIC OXIDE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
SIMVASTATIN;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTERY INTIMA PROLIFERATION;
ARTERY WALL;
ATHEROSCLEROSIS;
BIOAVAILABILITY;
BLOOD VESSEL GRAFT;
CARDIOVASCULAR DISEASE;
CELL PROLIFERATION;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS SURGERY;
CORONARY ARTERY DISEASE;
DEATH;
DRUG MEGADOSE;
ENDOTHELIAL DYSFUNCTION;
ENZYME INHIBITION;
HUMAN;
NONHUMAN;
PATHOGENESIS;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
RESTENOSIS;
REVIEW;
RISK REDUCTION;
STENT;
THROMBOSIS;
VASCULAR DISEASE;
VASCULAR ENDOTHELIUM;
VASCULAR SMOOTH MUSCLE;
VEIN GRAFT DISEASE;
|
|
EID: 34249022746
PISSN: 02639319
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpsur.2007.03.006 Document Type: Review |
|
Times cited : (7)
|
|
References (8)
|
